674,925 Shares in KORU Medical Systems, Inc. $KRMD Acquired by Simcoe Capital LLC

Simcoe Capital LLC acquired a new position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 674,925 shares of the company’s stock, valued at approximately $3,921,000. KORU Medical Systems comprises about 3.7% of Simcoe Capital LLC’s portfolio, making the stock its 10th biggest holding. Simcoe Capital LLC owned about 1.46% of KORU Medical Systems as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Acuitas Investments LLC boosted its stake in KORU Medical Systems by 89.6% during the 3rd quarter. Acuitas Investments LLC now owns 763,088 shares of the company’s stock worth $2,923,000 after acquiring an additional 360,594 shares during the last quarter. Topline Capital Management LLC boosted its stake in KORU Medical Systems by 1.1% during the 3rd quarter. Topline Capital Management LLC now owns 3,648,240 shares of the company’s stock worth $13,973,000 after acquiring an additional 39,893 shares during the last quarter. Vanguard Group Inc. boosted its stake in KORU Medical Systems by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 2,145,772 shares of the company’s stock worth $8,218,000 after acquiring an additional 60,109 shares during the last quarter. Geode Capital Management LLC boosted its stake in KORU Medical Systems by 101.3% during the 2nd quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock worth $3,571,000 after acquiring an additional 501,875 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in KORU Medical Systems by 189.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock worth $617,000 after acquiring an additional 158,914 shares during the last quarter. Institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Stock Performance

Shares of KRMD opened at $4.00 on Wednesday. KORU Medical Systems, Inc. has a twelve month low of $2.63 and a twelve month high of $6.61. The firm’s 50 day moving average price is $4.29 and its two-hundred day moving average price is $4.85. The firm has a market cap of $183.72 million, a P/E ratio of -80.00 and a beta of 0.43.

KORU Medical Systems (NASDAQ:KRMD) last announced its quarterly earnings results on Wednesday, May 6th. The company reported ($0.02) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.02). KORU Medical Systems had a negative net margin of 5.27% and a negative return on equity of 13.61%. The firm had revenue of $11.76 million for the quarter, compared to analyst estimates of $11.28 million. On average, sell-side analysts anticipate that KORU Medical Systems, Inc. will post -0.03 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on KRMD shares. Canaccord Genuity Group reissued a “buy” rating and set a $6.00 price objective on shares of KORU Medical Systems in a research note on Friday, March 13th. Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a research note on Tuesday, April 21st. Craig Hallum reissued a “buy” rating and set a $7.00 price objective on shares of KORU Medical Systems in a research note on Tuesday, January 13th. Wall Street Zen lowered shares of KORU Medical Systems from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, B. Riley Financial lifted their price target on shares of KORU Medical Systems from $7.00 to $8.00 and gave the company a “buy” rating in a research note on Friday, March 13th. Four research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $7.25.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.